Resolution Clears the Way for the Company to Focus Full-Time on Delivering the Highest-Quality Products to Customers
Santa Fe Springs, CA—Sept. 12—DNP International Co., Inc., one of the leading suppliers of nutritional ingredients in North America, announced today that it has reached an agreement with the federal government to accept responsibility for its failure to obtain a state license in connection with its 2007 sales of a pharmaceutical product called somatropin.
Resolution of this matter clears the way for DNP's management to focus full-time on continuing to deliver the highest-quality products to its valued customers at the most competitive prices.
The events giving rise to the agreed-upon charges occurred more than five years ago and had no impact on the company’s operations. Since that time, DNP has implemented measures to ensure that all of its importation and distribution activities comply to the letter with all federal, state and local laws and regulations.
Mr. Ji noted that both he and the company are pleased to have resolved this matter, and look forward to putting the issue behind the company. He stressed that customers can rest assured that DNP will continue to provide reliable, high-quality and reasonably priced nutritional materials and other fine ingredients from world class manufacturers with a focus on customer-valued distribution services.
DNP in dedicated to being the “best-in-class,” by creating value and exceeding expectations of its customers and employees through market leadership and operational excellence. For more information go to www.dnpint.com.
Contact: Robert Magnuson